Clinical Assessment of Breast Cancer Resistance Protein (BCRP)-Mediated Drug-Drug Interactions of Sepiapterin with Curcumin and Rosuvastatin in Healthy Volunteers
Abstract Background and Objective Sepiapterin, also known as PTC923 and CNSA-001, is a synthetic form of endogenous sepiapterin being developed as a novel oral treatment for phenylketonuria. Sepiapterin is a natural precursor of tetrahydrobiopterin (BH4) and, when orally administered, is converted t...
Saved in:
Main Authors: | Lan Gao (Author), Diksha Kaushik (Author), Kimberly Ingalls (Author), Sarah Milner (Author), Neil Smith (Author), Ronald Kong (Author) |
---|---|
Format: | Book |
Published: |
Adis, Springer Healthcare,
2024-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Phase 1 Study to Assess the Pharmacokinetics, Food Effect, Safety, and Tolerability of Sepiapterin in Healthy Japanese and Non-Japanese Participants
by: Lan Gao, et al.
Published: (2024) -
Evaluation of drug‐drug interaction potential between omecamtiv mecarbil and rosuvastatin, a BCRP substrate, with a clinical study in healthy subjects and using a physiologically‐based pharmacokinetic model
by: Ashit Trivedi, et al.
Published: (2021) -
Altered Expression of BCRP Impacts Fetal Accumulation of Rosuvastatin in a Rat Model of Preeclampsia
by: Wanying Dai, et al.
Published: (2024) -
A pharmacokinetic drug-drug interaction study between rosuvastatin and emvododstat, a potent anti‐SARS‐CoV‐2 (COVID‐19) DHODH (dihydroorotate dehydrogenase) inhibitor
by: Terri L. Morton, et al.
Published: (2023) -
Diagnosis and Treatment of Sepiapterin Reductase Deficiency
by: J Gordon Millichap
Published: (2006)